Literature DB >> 6470747

In situ formation of immune complexes in the choroid plexus of rats by sequential injection of a cationized antigen and unaltered antibodies.

J T Huang, M Mannik, J Gleisner.   

Abstract

The deposition of cationized human serum albumin (HSAED) in the choroid plexus of rats was compared to deposition in renal glomeruli. Initial deposition in the choroid plexus required a higher dose of antigen than deposition in glomeruli. The optimal dose for deposition in the choroid plexus was 50 mg/kg of HSAED. With this dose the antigen was still present in the choroid plexus at eight days after injection, whereas the glomeruli became largely negative by one day. Immune complex formation and persistence was examined in the choroid plexus by injecting rabbit antibodies to HSA at varying times after the injection of HSAED. When a limited amount of antibody was injected, it localized preferentially to glomeruli as compared to the choroid plexus. When sufficient antibodies were injected, the antigen and antibodies persisted in a comparable manner in the choroid plexus and glomeruli. By the eighth day after injection of foreign proteins, rat IgG deposited in both organs, indicating an endogenous immune response. The formed deposits were still present at 28 days, containing HSA, rabbit IgG, and rat IgG, but not rat C3. These results indicate that immune deposits readily form in the choroid plexus after injecting a cationized antigen. Differences, however, exist in the formation of immune deposit in the choroid plexus and the glomeruli.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470747     DOI: 10.1097/00005072-198409000-00004

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Frequent vaccination and immune complex deposition in unilateral nephrectomized mice.

Authors:  Semra Kurul; Salih Kavukcu; Banu Sis; Osman Yilmaz; Sulen Sarioglu; Alper Soylu; Mehmet Turkmen; Eray Dirik
Journal:  Pediatr Nephrol       Date:  2004-03-20       Impact factor: 3.714

Review 2.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

Review 3.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

4.  The effects of chronic serum sickness on albumin distribution and glucose utilization in rat brain.

Authors:  H Nakata; A Shimizu; A Tajima; S Z Lin; K Gruber; E Perillo; N Peress; J Fenstermacher
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  The superficial basal lamina of ciliary processes: binding studies with IgG-immunogold and ferritins.

Authors:  N S Peress; E Perillo
Journal:  Cell Tissue Res       Date:  1995-02       Impact factor: 5.249

6.  Anti-nuclear antibodies positive serum from systemic lupus erythematosus patients promotes cardiovascular manifestations and the presence of human antibody in the brain.

Authors:  Marie Kelly-Worden; Leslie Hammer; Robyn Gebhard; Lauran Schrader; Marley Griffin; Dalahnna Cooper
Journal:  J Pharm Bioallied Sci       Date:  2014-07

7.  Complement and Humoral Adaptive Immunity in the Human Choroid Plexus: Roles for Stromal Concretions, Basement Membranes, and Epithelium.

Authors:  G R Wayne Moore; Cornelia Laule; Esther Leung; Vladimira Pavlova; B Paul Morgan; Margaret M Esiri
Journal:  J Neuropathol Exp Neurol       Date:  2016-03-19       Impact factor: 3.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.